SecBot SecBot
6-K ·Filed Nov 3, 2026

CMMB

Chemomab Therapeutics Ltd.
NEUTRAL
Impact 4/10
Horizonweeks Processed13d 16h ago SEC0001178913-26-004976
Notable filing: 6-K
Actionable Insight • Neutral

The effective S-4 and this incorporation filing signal the merger is progressing toward a shareholder vote and closing. Monitor for the record date, proxy mailing, and shareholder meeting announcement.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$1.18
T+0 close · Nov 3, 2026 · via day close
Latest settled
+13.98%
T+5 · $1.35 · next T+20 in 15d
Vs SPY
+14.57%
α at T+5
Latest observation
+35.80%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $1.18entry
  2. T+1 · 13d ago +4.24%α +2.59% · $1.23
  3. T+5 · 7d ago +13.98%α +14.57% · $1.35
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Chemomab Therapeutics filed a Form 6-K to incorporate by reference into its registration statements the S-4 registration statement for its pending merger with Scipher Medicine Corporation, which was declared effective on October 30, 2026. The filing includes audited and unaudited financial statements of both companies and pro forma combined financial information. This is a procedural step advancing the merger, which was originally announced on July 7, 2026.

Key Facts

  • Chemomab entered into a merger agreement on July 7, 2026 with Snowdrift Parent Corporation, Snowdrift Sub Corp., Elderwood Ltd. and Scipher Medicine Corporation.
  • The S-4 registration statement was declared effective by the SEC on October 30, 2026.
  • This 6-K incorporates by reference selected definitions, business descriptions, financial statements, and pro forma combined financial information from the S-4 into Chemomab's existing F-3 and S-8 registration statements.
  • The consent of Deloitte & Touche LLP, Scipher's independent auditor, is filed as Exhibit 23.1.

Financial Impact

No financial figures stated in this filing; the merger consideration is not disclosed here.

Risk Factors

  • Merger may not close if conditions are not satisfied or if shareholders do not approve.
  • Chemomab has a market cap of $9M and the deal structure is not detailed here; post-merger dilution and cash position are unknown.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001178913-26-004976
Exhibit: exhibit_23-1.htm0001178913-26-004976
Document: 0001178913-26-004976-index-headers.html0001178913-26-004976
Document: 0001178913-26-004976-index.html0001178913-26-004976
Document: 0001178913-26-004976.txt0001178913-26-004976
Earnings Context (Synthetic; results releases only)0001178913-26-004976

Track record

15 reports on CMMB

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +33.01% at T+60 after the Aug 19, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13D Neutral 5/10 Entry $1.35 Now $1.62 +20.00% settles Feb 9
  2. Nov 10, 20266d ago DEFA14A Neutral 5/10 Entry $1.35 Now $1.62 +20.00% settles Feb 9
  3. Nov 3, 202613d ago 6-K Neutral 4/10 Viewing Entry $1.18 Now $1.62 +37.29% settles Feb 1
  4. Nov 2, 202614d ago Press Release Neutral 5/10 Entry $1.18 Now $1.62 +37.29% settles Jan 29
  5. Oct 30, 202617d ago DEFM14A Neutral 6/10 Entry $1.18 Now $1.62 +37.29% settles Jan 29
  6. Oct 19, 202628d ago 6-K Neutral 3/10 Entry $1.18 Now $1.62 +37.29% settles Jan 15
  7. Sep 30, 20266w ago 6-K Neutral 4/10 Entry $1.30 Now $1.62 +24.62% settles Dec 28
  8. Aug 19, 202612w ago 6-K Neutral 6/10 Entry $2.09 to $1.40 Now $1.62 −22.49% ▼ −33.01% −31.46% vs SPY
  9. Aug 19, 202612w ago Press Release Bearish 6/10 Entry $2.09 to $1.40 Now $1.62 +22.49% ▲ +33.01% +31.46% vs SPY
  10. Jul 8, 202618w ago 6-K Bullish 7/10 Entry $1.97 to $1.19 Now $1.62 −17.77% ▼ −39.59% −41.91% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 8h 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026